US Stock MarketDetailed Quotes

PRQR ProQR Therapeutics

Watchlist
  • 1.9400
  • -0.0200-1.02%
Close Apr 26 16:00 ET
157.83MMarket Cap-5187P/E (TTM)

ProQR Therapeutics Key Stats

ProQR Therapeutics Earnings Date

Currency: EUR

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

3.28M

+356.11%
EPS(YoY)

-0.07

+61.11%

Strong Buy

Apr 18, 2024

ProQR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 2.857M--
--2024/Q1-- / 2.857M--
--2023/Q46.786M / 15.902M--
--2023/Q31.472M / 3.647M--
--2023/Q21.359M / 1.318M--
--2023/Q1757.770K / 1.431M--
Mar 29, 20232022/Q41.422M / 1.002M--
--2022/Q31.035M / 862.720K--
--2022/Q21.150M / 947.180K--
--2022/Q11.402M / 884.760K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 2.857M--
--2024/Q1-- / 2.857M--
--2023/Q46.786M / 15.902M--
--2023/Q31.472M / 3.647M--
--2023/Q21.359M / 1.318M--
--2023/Q1757.770K / 1.431M--
Mar 29, 20232022/Q41.422M / 1.002M--
--2022/Q31.035M / 862.720K--
--2022/Q21.150M / 947.180K--
--2022/Q11.402M / 884.760K--

Unlock Free Earnings Estimates

ProQR Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 18, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg